[email protected] +1 646 480 7505 (U.S.) | +44 203 318 2846 (U.K.)

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Preimplantation Genetic Testing Market

3.3       Key Market Trends

3.3.1    Drivers

3.3.2    Restraints

3.3.3    Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1    Bargaining Power of Suppliers

3.4.2    Bargaining Power of Buyers

3.4.3    Threat of Substitution

3.4.4    Threat of New Entrants

3.4.5    Competitive Rivalry

3.5       Market Share Analysis

4          Procedure Type Overview

4.1       Introduction

4.1.1    Market Size & Forecast

4.2       Preimplantation Genetic Screening

4.3       Preimplantation Genetic Diagnosis

5          Product and Service Overview

5.1       Introduction

5.1.1    Market Size & Forecast

5.2       Reagents and Consumables

5.3       Instruments

5.4       Software and Services

6          Application Overview

6.1       Introduction

6.1.1    Market Size & Forecast

6.2       Structural Chromosomal Abnormalities

6.2.1    Market Size & Forecast

6.2.2    Translocations

6.2.3    Deletions

6.2.4    Duplications

6.2.5    Inversions

6.3       X-Linked Disorders

6.4       HLA Typing

6.5       Single Gene Disorder Screening

6.6       Aneuploidy Screening

6.7       Gender Identification

7          End User Overview

7.1       Introduction

7.1.1    Market Size & Forecast

7.2       Hospitals

7.3       Diagnostic Laboratories

7.4       Research & Academic Centers

7.5       Fertility Clinics & Maternity Centers

8          Regional Overview

8.1       Introduction

8.1.1    Market Size & Forecast

8.2       America

8.2.1    North America

8.2.1.1 U.S.

8.2.1.1.1          By Procedure Type

8.2.1.1.2          By Application

8.2.1.1.3          By End User

8.2.1.2 Canada

8.2.1.2.1          By Procedure Type

8.2.1.2.2          By Application

8.2.1.2.3          By End User

8.2.1.3 Mexico

8.2.1.3.1          By Procedure Type

8.2.1.3.2          By Application

8.2.1.3.3          By End User

8.2.2    South America

8.2.2.1             By Procedure Type

8.2.2.2             By Application

8.2.2.3             By End User

8.3       Europe           

8.3.1    Market Size & Forecast (Value)         

8.3.2    Western Europe

8.3.2.1 Germany    

8.3.2.1.1          By Procedure Type     

8.3.2.1.2          By Application            

8.3.2.1.3          By End User

8.3.2.2 France        

8.3.2.2.1          By Procedure Type     

8.3.2.2.2          By Application

8.3.2.2.3          By End User    

8.3.2.3 U.K.

8.3.2.3.1          By Procedure Type     

8.3.2.3.2          By Application

8.3.2.3.3          By End User    

8.3.2.4 Italy

8.3.2.4.1          By Procedure Type     

8.3.2.4.2          By Application

8.3.2.4.3          By End User    

8.3.2.5 Spain          

8.3.2.5.1          By Procedure Type     

8.3.2.5.2          By Application

8.3.2.5.3          By End User    

8.3.2.6 Rest of Western Europe    

8.3.2.6.1          By Procedure Type

8.3.2.6.2          By Application

8.3.2.6.3          By End User

8.3.3    Eastern Europe

8.4       Asia Pacific    

8.4.1    Market Size & Forecast (Value)         

8.4.2    China  

8.4.2.1           By Procedure Type

8.4.2.2           By Application

8.4.2.3           By End User

8.4.3    India

8.4.3.1           By Procedure Type

8.4.3.2           By Application

8.4.3.3           By End User

8.4.4    Japan  

8.4.4.1           By Procedure Type       

8.4.4.2           By Application

8.4.4.3           By End User      

8.4.5    South Korea    

8.4.5.1           By Procedure Type       

8.4.5.2           By Application

8.4.5.3           By End User

8.4.6    Australia         

8.4.6.1           By Procedure Type       

8.4.6.2           By Application

8.4.6.3           By End User

8.4.7    Rest of Asia-Pacific    

8.4.7.1           By Procedure Type       

8.4.7.2           By Application

8.4.7.3           By End User      

8.5       Middle East & Africa

8.5.1    Market Size & Forecast (Value)         

8.5.2    The Middle East

8.5.2.1 South Africa

8.5.2.1.1          By Procedure Type     

8.5.2.1.2          By Application

8.5.2.1.3          By End User

8.5.2.2 UAE

8.5.2.2.1          By Procedure Type    

8.5.2.2.2          By Application

8.5.2.2.3          By End User    

8.5.2.3 Qatar

8.5.2.3.1          By Procedure Type    

8.5.2.3.2          By Application

8.5.2.3.3          By End User    

8.5.2.4 Rest of Middle East

8.5.2.4.1          By Procedure Type

8.5.2.4 2          By Application

8.5.2.4 3          By End User

9.         Company Profile                  

9.1       Illumina, Inc.

9.1.1    Company Overview   

9.1.2    Financial Performance          

9.1.3    Recent Developments

9.1.4    Product Portfolio        

9.2       SciGene Corporation

9.2.1    Company Overview   

9.2.2    Financial Performance          

9.2.3    Recent Developments

9.2.4    Product Portfolio        

9.3       Thermo Fisher Scientific Inc.

9.3.1    Company Overview   

9.3.2    Financial Performance          

9.3.3    Recent Developments

9.3.4    Product Portfolio        

9.4       Agilent Technologies, Inc.

9.4.1    Company Overview   

9.4.2    Financial Performance          

9.4.3    Recent Developments

9.4.4    Product Portfolio        

9.5       Yikon Genomics

9.5.1    Company Overview   

9.5.2    Financial Performance          

9.5.3    Recent Developments

9.5.4    Product Portfolio        

9.6       Oxford Gene Technology

9.6.1    Company Overview   

9.6.2    Financial Performance          

9.6.3    Recent Developments

9.6.4    Product Portfolio        

9.7       Rubicon Genomics, Inc.

9.7.1    Company Overview   

9.7.2    Financial Performance          

9.7.3    Recent Developments

9.7.4    Product Portfolio        

9.8       Natera, Inc.

9.8.1    Company Overview   

9.8.2    Financial Performance          

9.8.3    Recent Developments

9.8.4    Product Portfolio        

9.9       Abbott

9.9.1    Company Overview   

9.9.2    Financial Performance          

9.9.3    Recent Developments

9.9.4    Product Portfolio        

9.10     CooperSurgical, Inc.

9.10.1  Company Overview   

9.10.2  Financial Performance          

9.10.3  Recent Developments

9.10.4  Product Portfolio



Request For Free Sample
Choose license Type

Buy Chapters or Sections

Avail customized purchase option to meet your exact research needs:

1)Buy sections of the report
2)Buy country level report
3)Request for historical data

Request a Free Sample   Special Pricing
Related Reports